BI-RADS5 Meme Lezyonlarında Sonoelastografinin Tanısal Yeri
[ X ]
Tarih
2018
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Kırıkkale Üniversitesi
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Amaç:Son yıllarda meme lezyonlarının değerlendirilmesinde sonoelastografi giderekdaha fazla kullanılmaktadır. Çalışmamızın amacı Meme Görüntüleme Raporlama veVeri Sistemi (BI-RADS) 5 olan meme lezyonların sonoelastografi incelemesi ilesaptanan elastografi skoru ve histopatolojik sonuçlarını karşılaştırmak vesonoelastografinin meme tümörlerinin malignitesini belirlemedekikullanılabilirliğini belirlemektir.Gereç veYöntemler: Prospektif çalışmamız Aralık 2014 Şubat 2015 tarihleri arasındayapıldı. Ultrasonografide BI-RADS 5 olarak değerlendirilen 44 hastanın yaş,kitle yeri, büyüklüğü, elastografi skorları ve eksizyonel biyopsi sonuçlarıdeğerlendirildi.Bulgular:Çalışmamızdaki hastaların yaş ortalaması 50.02±14.28 yıl idi. Hastaların%52.3’ünde kitle sol memede idi ve kitlelerin ortalama boyu 16.93±12.96 mm veortalama eni 23.39±14.77 mm’idi. Olguların %97.7’si maligndi. En sıkrastlanılan kitle patolojik tipi invazif duktal karsinomdu (%86.4).Çalışmamızda elastografinin duyarlılığı %97.7 olarak saptandı. Malign grubunelastikiyet skoru ve malignite varlığı arasında anlamlı ilişki saptanmadı(p and gt;0.05).Sonuç:Non-invaziv, tekrarlanabilir ve kullanımı kolay bir görüntüleme yöntemi olansonoelastografi, malign meme lezyonlarının (BI-RADS 5) gösterilmesinde sensitivitesioldukça yüksek bir test olup, malign meme lezyonlarının ayrımındakullanılabilir.
Objective: Sonoelastography is increasinglyused in the evaluation of breast lesions in recent years. The aim of our studyis to compare the sonoelastography scores found inthe sonoelastography examination and histopathological results ofBreast Imaging Reporting and Data System (BI-RADS) 5 breast lesions and todetermine the usefulness of sonoelastography for identifying themalignancy of the breast tumors.Material and Methods: Our prospective studyevaluated the age, mass location, size, elastography score, and excisionalbiopsy results of 44 patients assessed as BI-RADS 5 on ultrasonography betweenDecember 2014 and February 2015.Results: The mean age of the study populationwas 50.02±14.28 years. In 52.3% of the patients, the mass was located in theleft breast the masses had a mean length of 16.93±12.96 mm and a meanwidth of 23.39±14.77 mm. Ninety-seven-point seven percent of the cases weremalignant in nature. The most common mass histopathology wasinvasive ductal carcinoma (86.4%). The sensitivityof sonoelastography was 97.7%. No relationship between the elasticityscore and the presence of malignancy in the malignant group (p and gt;0.05).Conclusion: Sonoelastography, which is anoninvasive, reproducible and easy-to-use imaging method is a highlysensitive test for showing malignant breast lesions (BI-RADS 5) can beused for distinction of malignant breast lesions.
Objective: Sonoelastography is increasinglyused in the evaluation of breast lesions in recent years. The aim of our studyis to compare the sonoelastography scores found inthe sonoelastography examination and histopathological results ofBreast Imaging Reporting and Data System (BI-RADS) 5 breast lesions and todetermine the usefulness of sonoelastography for identifying themalignancy of the breast tumors.Material and Methods: Our prospective studyevaluated the age, mass location, size, elastography score, and excisionalbiopsy results of 44 patients assessed as BI-RADS 5 on ultrasonography betweenDecember 2014 and February 2015.Results: The mean age of the study populationwas 50.02±14.28 years. In 52.3% of the patients, the mass was located in theleft breast the masses had a mean length of 16.93±12.96 mm and a meanwidth of 23.39±14.77 mm. Ninety-seven-point seven percent of the cases weremalignant in nature. The most common mass histopathology wasinvasive ductal carcinoma (86.4%). The sensitivityof sonoelastography was 97.7%. No relationship between the elasticityscore and the presence of malignancy in the malignant group (p and gt;0.05).Conclusion: Sonoelastography, which is anoninvasive, reproducible and easy-to-use imaging method is a highlysensitive test for showing malignant breast lesions (BI-RADS 5) can beused for distinction of malignant breast lesions.
Açıklama
Anahtar Kelimeler
BI-RADS 5, sonoelastografi, malign meme kanseri, BI-RADS5, sonoelastography, malignant breast cancer, Health Care Administration
Kaynak
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
2
Sayı
3-263
